Citations

Clear

1893 citation(s) found for "Wu, Kenneth".

Cardiorespiratory effects of inelastic chest wall restriction
Miller, Jordan D. , Beck, Kenneth C., Brice, A. G., Johnson, Bruce D., Joyner, Michael J. , Miller, Jordan

Mayo Clinic

Journal of Applied Physiology | March 3, 2015 | Volume: 92 | Issue: 6 | Pages: 2419-2428

10.1152/japplphysiol.00394.2001 | PMID 12015356 Get It

We examined the effects of chest wall restriction (CWR) on cardiorespiratory function at rest and during exercise in healthy subjects in an attempt to approximate the cardiorespiratory interactions observed in clinical conditions that result in restrictive lung and/or chest wall changes and a reduced intrathoracic space. Canvas straps were applied around the thorax and abdomen so that vital capacity was reduced by >35%. Data were acquired at rest and during cycle ergometry at 25 and 45% of peak workloads. CWR elicited significant increases in the flow-resistive work performed on the lung (160%) and the gastric pressure-time integral (>400%) at the higher workload, but it resulted in a decrease in the elastic work performed on the lung (56%) compared with control conditions. With CWR, heart rate increased and stroke volume (SV) fell, resulting in >10% fall in cardiac output at rest and during exercise at matched workloads ( P < 0.05). Blood pressure and catecholamines were significantly elevated during CWR exercise conditions ( P < 0.05). We conclude that CWR significantly impairs SV during exercise and that a compensatory increase in heart rate does not prevent a significant reduction in cardiac output. O2consumption appears to be maintained via increased extraction and a redistribution of blood flow via sympathetic activation.
Impedance, gas mixing, and bimodal ventilation in constricted lungs
Anafi, Ron C. , Beck, Kenneth C., Wilson, Theodore A., Anafi, Ron C

Mayo Clinic

Journal of Applied Physiology | March 3, 2015 | Volume: 94 | Issue: 3 | Pages: 1003-1011

10.1152/japplphysiol.00569.2002 | PMID 12571131 Get It

To evaluate the effect of increasing smooth muscle activation on the distribution of ventilation, lung impedance and expired gas concentrations were measured during a 16-breath He-washin maneuver in five nonasthmatic subjects at baseline and after each of three doses of aerosolized methacholine. Values of dynamic lung elastance (El,dyn), the curvature of washin plots, and the normalized slope of phase III ( S N ) were obtained. At the highest dose, El,dyn was 2.6 times the control value and S N for the 16th breath was 0.65 liter −1 . A previously described model of a constricted terminal airway was extended to include variable muscle activation, and the extended model was tested against these data. The model predicts that the constricted airway has two stable states. The impedances of the two stable states are independent of smooth muscle activation, but driving pressure and the number of airways in the high-resistance state increase with increasing muscle activation. Model predictions and experimental data agree well. We conclude that, as a result of the bistability of the terminal airways, the ventilation distribution in the constricted lung is bimodal.
Heart rate is associated with progression of atrial fibrillation, independent of rhythm
Holmqvist, Fredrik , Kim, Sunghee , Steinberg, Benjamin A. , Reiffel, James A. , Mahaffey, Kenneth W. , Fonarow, Gregg C. , Chang, Paul, Kowey, Peter R. , Thomas, Laine , Piccini, Jonathan P. , Gersh, Bernard J. , Naccarelli, Gerald V. , Freeman, James V. , Peterson, Eric D. , Steinberg, Benjamin A

Mayo Clinic

Heart | March 2, 2015 | Volume: 101 | Issue: 11 | Pages: 894-899

10.1136/heartjnl-2014-307043 | PMID 25732748 Get It

Objective Atrial fibrillation (AF) often progresses from paroxysmal or persistent to more sustained forms, but the rate and predictors of AF progression in clinical practice are not well described. Methods Using the Outcomes Registry for Better Informed Treatment of AF, we analysed the incidence and predictors of progression and tested the discrimination and calibration of the HATCH (hypertension, age, TIA/stroke, chronic obstructive pulmonary disease, heart failure) and CHA2DS2VASc scores for identifying AF progression. Results Among 6235 patients with paroxysmal or persistent AF at baseline, 1479 progressed, during follow-up (median 18 (IQR 12–24) months). These patients were older and had more comorbidities than patients who did not progress (CHADS2 2.3±1.3 vs 2.1±1.3, p<0.0001). At baseline, patients with AF progression were more often on a rate control as opposed to a rhythm control strategy (66 vs 56%, p<0.0001) and had higher heart rate (72(64–80) vs 68(60–76) bpm, p<0.0001). The strongest predictors of AF progression were AF on the baseline ECG (OR 2.30, 95% CI 1.95 to 2.73, p<0.0001) and increasing age (OR 1.16, 95% CI1.09 to 1.24, p<0.0001, per 10 increase), while patients with lower heart rate (OR 0.84, 95% CI 0.79 to 0.89, p<0.0001, per 10 decrease ≤80) were less likely to progress. There was no significant interaction between rhythm on baseline ECG and heart rate (p=0.71). The HATCH and CHA2DS2VASc scores had modest discriminatory power for AF progression (C-indices 0.55 (95% CI 0.53 to 0.58) and 0.55 (95% CI 0.52 to 0.57)). Conclusions Within 1.5 years, almost a quarter of the patients with paroxysmal or persistent AF progress to a more sustained form. Progression is strongly associated with heart rate, and age.
Implementing a Radiology–Information Technology Project: Mobile Image Viewing Use Case and a General Guideline for Radiologist–Information Technology Team Collaboration
Walz‐Flannigan, Alisa , Hein, Shelly, Persons, Kenneth R. , Langer, Steve G., Tjelta, Jason A., Kotsenas, Amy L. , Erickson, Bradley J. , Luetmer, Patrick H.

Mayo Clinic

American Journal of Roentgenology | February 25, 2015 | Volume: 204 | Issue: 4 | Pages: 721-726

10.2214/ajr.14.13880 | PMID 25714113 Get It

PD-1 Restrains Radiotherapy-Induced Abscopal Effect
Park, Sean S. , Dong, Haidong , Liu, Xin , Harrington, Susan M. , Krco, Christopher J., Mansfield, Aaron S. , Olivier, Kenneth R. , Kwon, Eugene D., Grams, Michael P. , Furutani, Keith M. , Mansfield, Aaron S , Dong, Haidong , Park, Sean S

Mayo Clinic

Cancer Immunology Research | February 21, 2015 | Volume: 3 | Issue: 6 | Pages: 610-619

10.1158/2326-6066.cir-14-0138 | PMID 25701325 Get It

Abstract We investigated the influence of PD-1 expression on the systemic antitumor response (abscopal effect) induced by stereotactic ablative radiotherapy (SABR) in preclinical melanoma and renal cell carcinoma models. We compared the SABR-induced antitumor response in PD-1–expressing wild-type (WT) and PD-1–deficient knockout (KO) mice and found that PD-1 expression compromises the survival of tumor-bearing mice treated with SABR. None of the PD-1 WT mice survived beyond 25 days, whereas 20% of the PD-1 KO mice survived beyond 40 days. Similarly, PD-1–blocking antibody in WT mice was able to recapitulate SABR-induced antitumor responses observed in PD-1 KO mice and led to increased survival. The combination of SABR plus PD-1 blockade induced near complete regression of the irradiated primary tumor (synergistic effect), as opposed to SABR alone or SABR plus control antibody. The combination of SABR plus PD-1 blockade therapy elicited a 66% reduction in size of nonirradiated, secondary tumors outside the SABR radiation field (abscopal effect). The observed abscopal effect was tumor specific and was not dependent on tumor histology or host genetic background. The CD11ahigh CD8+ T-cell phenotype identifies a tumor-reactive population, which was associated in frequency and function with a SABR-induced antitumor immune response in PD-1 KO mice. We conclude that SABR induces an abscopal tumor-specific immune response in both the irradiated and nonirradiated tumors, which is potentiated by PD-1 blockade. The combination of SABR and PD-1 blockade has the potential to translate into a potent immunotherapy strategy in the management of patients with metastatic cancer. Cancer Immunol Res; 3(6); 610–9. ©2015 AACR.
A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer
Stegeman, Shane, Amankwah, Ernest K. , Klein, Kerenaftali, Kim, Donghwa , Lin, Hui‐Yi , Permuth‐Wey, Jennifer, Sellers, Thomas A. , Srinivasan, Srilakshmi , Eeles, Rosalind A. , Easton, Doug , Olama, Ali Amin Al , Benlloch, Sara, Muir, Kenneth , Wiklund, Fredrik, Grönberg, Henrik , Haiman, Christopher A. , Schleutker, Johanna , Nordestgaard, Børge G. , Travis, Ruth C. , Neal, David E. , Stanford, Janet L. , Blot, William J. , Thibodeau, Stephen N. , Maier, Christiane, Kibel, Adam S. , Brenner, Hermann , Kaneva, Radka , Teixeira, Manuel R. , BioResource, Australian Prostate Cancer, Clements, Judith A. , Batra, Jyotsna , Wahlfors, Tiina , Leongamornlert, Daniel , Southey, Melissa C. , Schumacher, Fredrick R. , Henrique, Rui , Hamdy, Freddie C. , Donovan, Jenny , Pashayan, Nora , Weischer, Maren , Saunders, Edward J. , Mitev, Vanio , Maia, Sofia , Tilley, Wayne D. , Thibodeau, Stephen, O’Mara, Tracy A. , Kote‐Jarai, Zsofia , Giles, Graham G. , Pharoah, Paul D.P. , Khaw, Kay‐Tee , Cybulski, Cezary , Cannon‐Albright, Lisa , BioResource, Australian Prostate Cancer, Spurdle, Amanda B. , Park, Jong Y. , Paulo, Paula , Teixeira, Manuel R , Eeles, Rosalind A , Southey, Melissa C , Donovan, Jenny L , Muir, Kenneth , Schleutker, Johanna , Travis, Ruth C , Pashayan, Nora , Lin, Hui-Yi , Brenner, Hermann , Pinto, Pedro , Batra, Jyotsna , Clements, Judith

Mayo Clinic

Cancer Discovery | February 17, 2015 | Volume: 5 | Issue: 4 | Pages: 368-379

10.1158/2159-8290.cd-14-1057 | PMID 25691096 Get It

Abstract Prostate cancer is the second most common malignancy among men worldwide. Genome-wide association studies have identified 100 risk variants for prostate cancer, which can explain approximately 33% of the familial risk of the disease. We hypothesized that a comprehensive analysis of genetic variations found within the 3′ untranslated region of genes predicted to affect miRNA binding (miRSNP) can identify additional prostate cancer risk variants. We investigated the association between 2,169 miRSNPs and prostate cancer risk in a large-scale analysis of 22,301 cases and 22,320 controls of European ancestry from 23 participating studies. Twenty-two miRSNPs were associated (P &lt; 2.3 × 10−5) with risk of prostate cancer, 10 of which were within 7 genes previously not mapped by GWAS studies. Further, using miRNA mimics and reporter gene assays, we showed that miR-3162-5p has specific affinity for the KLK3 rs1058205 miRSNP T-allele, whereas miR-370 has greater affinity for the VAMP8 rs1010 miRSNP A-allele, validating their functional role. Significance: Findings from this large association study suggest that a focus on miRSNPs, including functional evaluation, can identify candidate risk loci below currently accepted statistical levels of genome-wide significance. Studies of miRNAs and their interactions with SNPs could provide further insights into the mechanisms of prostate cancer risk. Cancer Discov; 5(4); 368–79. ©2015 AACR. See related commentary by Yousef, p. 351 This article is highlighted in the In This Issue feature, p. 333
Troubleshooting Implantable Cardioverter-Defibrillator Sensing Problems II
Swerdlow, Charles D. , Asirvatham, Samuel J. , Ellenbogen, Kenneth A. , Friedman, Paul A. , Asirvatham, Samuel J , Ellenbogen, Kenneth A

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | February 17, 2015 | Volume: 8 | Issue: 1 | Pages: 212-220

10.1161/circep.114.002514 | PMID 25691555 Get It

Association of Actual and Preferred Decision Roles With Patient-Reported Quality of Care
Kehl, Kenneth L. , Landrum, Mary Beth , Arora, Neeraj K. , Ganz, Patricia A. , Ryn, Michelle van , Mack, Jennifer W. , Keating, Nancy L. , van Ryn, Michelle, van Ryn, Michelle

Mayo Clinic

JAMA Oncology | February 12, 2015 | Volume: 1 | Issue: 1 | Pages: 50

10.1001/jamaoncol.2014.112 | PMID 26182303 Get It

Weak peristalsis with large breaks in chronic cough: association with poor esophageal clearance
Smith, John A. , Valdramidou, D., Lee, A. S., DeVault, Kenneth R. , Houghton, Lesley A. , Almansa, Cristina , Morris, Jonathan , Crowell, Michael D. , Houghton, L A

Mayo Clinic

Neurogastroenterology & Motility | January 28, 2015 | Volume: 27 | Issue: 3 | Pages: 431-442

10.1111/nmo.12513 | PMID 25628004 Get It

AbstractBackgroundGastroesophageal reflux plays an important role in chronic cough (CC). Whether disturbed esophageal motility contributes to increased esophageal reflux exposure or interferes with swallowed bolus clearance is unclear. This study used high resolution esophageal manometry and impedance (HRIM) together with Chicago Classification, and 24‐h impedance pH (MII/pH) to address these questions in patients with CC compared with heartburn (HB).MethodsA retrospective review of 32 patients with CC (mean age 57 [95% CI: 52–62] years) and 32 patients with symptoms of HB (55 [52–62] years) referred for HRIM and MII/pH between September 2012 and September 2013 was undertaken.Key ResultsWeak peristalsis with large breaks (WPLBs) was observed in 34% of CC patients compared with only 12% of HB patients (p = 0.027). Pathological acid exposure time (AET) was identified in 81% of CC patients with WPLBs compared with 29% without (p = 0.011). Increased AET was associated with prolonged clearance time of refluxed events (p = 0.006) rather than increased number of events. AET correlated with the percentage of peristaltic events with large breaks in CC (ρ = 0.467, p = 0.007). Similar data were obtained for total bolus (acid and non‐acid) exposure time. Only one of the CC patients with WPLBs exhibited complete bolus transit (CBT) on swallowing compared with 81% without WPLBs (p < 0.001). Moreover, the percentage of peristaltic events associated with CBT negatively correlated with the percentage of peristaltic events with large breaks (r = −0.653, p < 0.001) in CC.Conclusions & InferencesOne‐third of CC patients exhibit WPLBs, which directly impacts on clearance of refluxed events and bolus's swallowed. These observations may have important implications for esophageal‐bronchial interaction in CC.
Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report
Palumbo, Antonio , Bringhen, Sara , Mateos, María‐Victoria , Larocca, Alessandra , Kumar, Shaji , Offidani, Massimo , Evangelista, Andrea , Zweegman, Sonja , Musto, Pellegrino , Terpos, Evangelos , Belch, Andrew , Hájek, Roman , Stewart, A. Keith, Moreau, Philippe , Durie, Brian G.M. , Dimopoulos, Meletios Α. , Miguel, Jesús F. San , Richardson, Paul G. , Sonneveld, Pieter , Facon, Thierry T.F. , McCarthy, Philip L. , Lonial, Sagar , Zweegman, Sonja , Ludwig, Heinz , Anderson, Kenneth C. , Einsele, Hermann , Landgren, Ola , Richardson, Paul Gerard Guy , Rajkumar, S. Vincent , Hajek, Roman , Dimopoulos, Meletios A , Moreau, Philippe , Terpos, Evangelos , San-Miguel, Jesus

Mayo Clinic

Blood | January 28, 2015 | Volume: 125 | Issue: 13 | Pages: 2068-2074

10.1182/blood-2014-12-615187 | PMID 25628469 Get It

Key Points Elderly patients with myeloma are heterogeneous and assessment strategies are needed to define the frailty profile. The proposed frailty score aims to better assess patients and provide them with more suitable therapies.